Oncocyte Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oncocyte Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • Oncocyte Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$13.5M, a 108% decline year-over-year.
  • Oncocyte Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$43.1M, a 24% increase year-over-year.
  • Oncocyte Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$27.8M, a 61.9% increase from 2022.
  • Oncocyte Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$72.9M, a 13.7% decline from 2021.
  • Oncocyte Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$64.1M, a 114% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$43.1M -$13.5M -$7M -108% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$36.1M -$4.53M +$3.8M +45.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$39.9M -$9.13M -$12.2M -401% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$27.8M -$16M +$29M +64.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$56.8M -$6.49M +$2.84M +30.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$59.6M -$8.33M -$33K -0.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$59.6M $3.03M +$13.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$72.9M -$45M -$9.09M -25.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$63.8M -$9.33M +$4.47M +32.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$68.3M -$8.3M +$2.19M +20.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$70.5M -$10.3M -$6.37M -163% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$64.1M -$35.9M -$29.6M -469% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 -$34.5M -$13.8M -$7.02M -103% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$27.5M -$10.5M -$1.39M -15.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$26.1M -$3.92M +$3.81M +49.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$29.9M -$6.31M +$1.65M +20.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$31.6M -$6.78M -$1.56M -29.8% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-11
Q2 2020 -$30M -$9.11M -$3.73M -69.2% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-11
Q1 2020 -$26.3M -$7.73M -$3.87M -100% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-11
Q4 2019 -$22.4M -$7.95M -$3.45M -76.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-19
Q3 2019 -$19M -$5.23M -$2.25M -75.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$16.7M -$5.38M -$878K -19.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$15.8M -$3.86M -$86K -2.28% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$15.8M -$4.5M -$539K -13.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$15.2M -$2.97M +$3.94M +57% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$19.2M -$4.51M -$701K -18.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$18.4M -$3.78M +$926K +19.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$19.4M -$3.96M -$859K -27.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$18.5M -$6.91M -$4.31M -166% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$14.2M -$3.8M -$1.26M -49.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$12.9M -$4.7M -$1.78M -60.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$11.2M -$3.1M +$437K +12.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$11.6M -$2.6M -$179K -7.41% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$11.4M -$2.54M -$1.13M -80.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$10.3M -$2.93M -$1.56M -114% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 -$8.74M -$3.54M Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 -$2.42M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$1.41M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$1.37M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.